Market Size – USD 4,820.5 Million in 2019, Market Growth – CAGR of 12.5%, Market Trends –Rise in the development and consumption rate of drugs
The report on the Pharmacovigilance market gives an in-depth statistical analysis to examine the fastest growing sectors in the market while speculating the demand and supply, consumption power, spending capacity and distribution channel globally. The report identifies the overall growth in the import and export and derives the future trends that the industry might witness. The study also applies primary and secondary research methods to assess the annual and financial performance of the top vendors and insights from market leaders. The researcher also discusses the recent trends and developments including joint ventures, collaborations, investments, product launches and acquisitions and mergers constitute a substantial part of the research on the Pharmacovigilance market for the forecast period from 2020 to 2027. The report will empower companies to understand the opportunities, adapt to their consumer demands, needs, and concentrate on their best end-users.
The report provides an in-depth analysis of the impact of the COVID-19 pandemic on the industry. The pandemic has brought a dynamic change in the economic scenario of the world. The report assesses the current market scenario and emerging opportunities and trends due to the COVID-19 pandemic. The market is poised to regain momentum over the next few years due to rapid advancements in the industry. The study also provides a detailed analysis of the present and future impact of COVID-19 on the market.
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/pharmacovigilance-market
Scope of the report
The research takes a closer look at prominent factors driving the growth rate of the prominent product categories across major geography. Furthermore, the study covers a lot of the sales, gross margin, consumption capacity, spending power and customer preference across various countries. The report offers clear indications how the Pharmacovigilance market is expected to witness numerous exciting opportunities in the years to come. Critical aspects including the growing requirement, demand and supply status, customer preference, distribution channels and others are presented through resources such as charts, tables, and infographics.
Key market players included in the study are:
ArisGlobal, Accenture, Cognizant, Capgemini, IBM Corporation, IQVIA, BoClinica Inc., Laboratory Corporation of America Holdings, Linical Accelovance, and ITClinical, among others.
The report analyzes the strategic alliances observed in the market for new products, partnerships, and collaborations between key players. The report investigates key aspects such as financial standing, research and development, product offerings, current deals, investments, and strategic alliances such as mergers and acquisitions, joint ventures, product launches, brand promotions, and corporate deals, among others.
Type Outlook (Revenue, USD Million; 2017-2027)
- Spontaneous Reporting
- Intensified Adverse Drug Reaction (ADR) Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- Electronic Health Record (HER) Mining
Service Provider Outlook (Revenue, USD Million; 2017-2027)
- In-House
- Contract Outsourcing
Clinical Trial Phase Outlook (Revenue, USD Million; 2017-2027)
- Pre-Clinical
- Phase I
- Phase II
- Phase III
- Phase IV
End-Users Outlook (Revenue, USD Million; 2017-2027)
- Hospitals
- Research Organizations
- Others
The study further explores and provides an in-depth analysis of current market dynamics and recent trends, focusing on various key factors and potential growth opportunities and risks. The report focuses on leading regions and their major countries to anticipate market growth in the forecast years. The major geographical regions included in the study are North America, Asia Pacific, Europe, Latin America, and Middle East & Africa.
Key Highlights from The Report
- In December 2019, UCB and Accenture made an announcement about signing of a partnership agreement to build a safety solution on INTIENT™ pharmacovigilance, by Accenture, to accelerate patient safety case reports’ processing. The agreement is intended to help UCB in discovering the influence of existing treatments on patient’s safety and therefore managing the novel drugs’ risk in a better way.
- Spontaneous reporting is a crucial type in pharmacovigilance by providing information from real clinical settings in the course of a drug’s life. Physicians and many other healthcare specialists contribute immensely to improving public health by supposed adverse drug reactions’ reporting.
The complete regional analysis covers:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Thank you for reading our report. For customization inquiries or further information, please connect with us, and we will ensure you get the report that meets your requirements.
